|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
1,770,000,000 |
Market
Cap: |
285.47(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$132.51 - $182.1 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 560 |
Guru Rank Value : 3 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
459,004 |
461,916 |
540,416 |
1,279,317 |
Total Sell Value |
$81,195,771 |
$81,646,316 |
$93,320,391 |
$207,372,438 |
Total People Sold |
9 |
9 |
9 |
14 |
Total Sell Transactions |
10 |
11 |
13 |
34 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Hart Brett J |
Director |
|
2018-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,899 |
7,643 |
|
- |
|
Roberts Rebecca B |
Director |
|
2018-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,899 |
1,899 |
|
- |
|
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2018-03-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,115 |
6,715 |
|
- |
|
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2018-03-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,722 |
307,290 |
|
- |
|
Schumacher Laura J |
Executive Vice President |
|
2018-03-01 |
4 |
S |
$117.85 |
$2,946,148 |
D/D |
(25,000) |
98,317 |
|
- |
|
Alban Carlos |
EVP, Commercial Operations |
|
2018-03-01 |
4 |
S |
$113.75 |
$9,264,808 |
D/D |
(80,995) |
97,552 |
|
- |
|
Alban Carlos |
EVP, Commercial Operations |
|
2018-03-01 |
4 |
OE |
$29.23 |
$1,405,795 |
D/D |
48,100 |
178,547 |
|
- |
|
Chase William J |
EVP, Chief Financial Officer |
|
2018-03-01 |
4 |
S |
$114.50 |
$3,709,687 |
D/D |
(32,400) |
164,863 |
|
- |
|
Chase William J |
EVP, Chief Financial Officer |
|
2018-03-01 |
4 |
OE |
$24.21 |
$839,339 |
D/D |
32,400 |
197,263 |
|
- |
|
Richmond Timothy J. |
SVP, Human Resources |
|
2018-02-28 |
4 |
S |
$118.67 |
$2,151,452 |
D/D |
(18,129) |
17,588 |
|
- |
|
Richmond Timothy J. |
SVP, Human Resources |
|
2018-02-28 |
4 |
D |
$118.26 |
$1,440,762 |
D/D |
(12,183) |
35,717 |
|
- |
|
Schumacher Laura J |
Executive Vice President |
|
2018-02-28 |
4 |
D |
$118.26 |
$3,291,767 |
D/D |
(27,835) |
123,317 |
|
- |
|
Severino Michael |
EVP, R&D and CSO |
|
2018-02-28 |
4 |
S |
$117.93 |
$311,684 |
D/D |
(2,643) |
132,281 |
|
- |
|
Severino Michael |
EVP, R&D and CSO |
|
2018-02-28 |
4 |
D |
$118.26 |
$3,273,792 |
D/D |
(27,683) |
134,924 |
|
- |
|
Alban Carlos |
EVP, Commercial Operations |
|
2018-02-28 |
4 |
S |
$117.85 |
$303,928 |
D/D |
(2,579) |
130,447 |
|
- |
|
Alban Carlos |
EVP, Commercial Operations |
|
2018-02-28 |
4 |
D |
$118.26 |
$3,071,922 |
D/D |
(25,976) |
133,026 |
|
- |
|
Saleki-Gerhardt Azita |
SVP, Operations |
|
2018-02-28 |
4 |
S |
$117.77 |
$157,458 |
D/D |
(1,337) |
93,312 |
|
- |
|
Saleki-Gerhardt Azita |
SVP, Operations |
|
2018-02-28 |
4 |
D |
$118.26 |
$1,499,892 |
D/D |
(12,683) |
94,649 |
|
- |
|
Chase William J |
EVP, Chief Financial Officer |
|
2018-02-28 |
4 |
S |
$119.44 |
$4,601,954 |
D/D |
(38,528) |
164,863 |
|
- |
|
Chase William J |
EVP, Chief Financial Officer |
|
2018-02-28 |
4 |
D |
$118.26 |
$3,359,412 |
D/D |
(28,407) |
203,391 |
|
- |
|
Gosebruch Henry O |
EVP, Chief Strategy Officer |
|
2018-02-28 |
4 |
D |
$118.26 |
$2,059,853 |
D/D |
(17,418) |
72,800 |
|
- |
|
Michael Robert A. |
VP, Controller |
|
2018-02-28 |
4 |
S |
$119.43 |
$512,853 |
D/D |
(4,294) |
6,876 |
|
- |
|
Michael Robert A. |
VP, Controller |
|
2018-02-28 |
4 |
D |
$118.26 |
$282,287 |
D/D |
(2,387) |
11,170 |
|
- |
|
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2018-02-28 |
4 |
S |
$117.88 |
$976,084 |
D/D |
(8,280) |
313,012 |
|
- |
|
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2018-02-28 |
4 |
D |
$118.26 |
$9,400,606 |
D/D |
(79,491) |
321,292 |
|
- |
|
641 Records found
|
|
Page 18 of 26 |
|
|